Go Pro

This company has been marked as potentially delisted and may not be actively trading.

Rapt Therapeutics (RAPT) News Today

Rapt Therapeutics logo

Rapt Therapeutics Latest News

GSK to buy Canada's 35Pharma for $950 million
Why Rapt Therapeutics Stock Soared Today
Why Rapt Therapeutics Stock Soared Today
GSK scoops up RAPT Therapeutics for $2.2bn
GSK to buy food allergy drug maker RAPT in $2.2bn deal
GSK to buy RAPT Therapeutics for $2.2 billion
Barclays Remains a Buy on RAPT Therapeutics (RAPT)

Rapt Therapeutics Media Mentions By Week

Rapt Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RAPT
News Sentiment

0.00

0.87

Average
Healthcare
News Sentiment

Rapt Therapeutics News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RAPT Articles
This Week

0

4

RAPT Articles
Average Week

Rapt Therapeutics Trends on MarketBeat

This week vs. last week
Searches
1
Page Views
549
+13%
Get Rapt Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAPT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Rapt Therapeutics dated 3/21/2026.
From Our Partners